BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Skrypnyk NI, Voziyan P, Yang H, de Caestecker CR, Theberge MC, Drouin M, Hudson B, Harris RC, de Caestecker MP. Pyridoxamine reduces postinjury fibrosis and improves functional recovery after acute kidney injury. Am J Physiol Renal Physiol 2016;311:F268-77. [PMID: 27194713 DOI: 10.1152/ajprenal.00056.2016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Forni LG, Darmon M, Ostermann M, Oudemans-van Straaten HM, Pettilä V, Prowle JR, Schetz M, Joannidis M. Renal recovery after acute kidney injury. Intensive Care Med 2017;43:855-66. [PMID: 28466146 DOI: 10.1007/s00134-017-4809-x] [Cited by in Crossref: 132] [Cited by in F6Publishing: 121] [Article Influence: 26.4] [Reference Citation Analysis]
2 Zhao R, Wan P, Shariati-ievari S, Aliani M, Shen GX. North American Wild Rice-Attenuated Hyperglycemia in High-Fat-Induced Obese Mice: Involvement of AMP-Activated Protein Kinase. J Agric Food Chem 2020;68:8855-62. [DOI: 10.1021/acs.jafc.0c03776] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Lattenist L, Lechner SM, Messaoudi S, Le Mercier A, El Moghrabi S, Prince S, Bobadilla NA, Kolkhof P, Jaisser F, Barrera-Chimal J. Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Protects Against Acute Kidney Injury-Mediated Chronic Kidney Disease: Role of Oxidative Stress. Hypertension. 2017;69:870-878. [PMID: 28320854 DOI: 10.1161/hypertensionaha.116.08526] [Cited by in Crossref: 43] [Cited by in F6Publishing: 19] [Article Influence: 8.6] [Reference Citation Analysis]
4 Davies SS, Zhang LS. Reactive Carbonyl Species Scavengers-Novel Therapeutic Approaches for Chronic Diseases. Curr Pharmacol Rep 2017;3:51-67. [PMID: 28993795 DOI: 10.1007/s40495-017-0081-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
5 Wei J, Zhang J, Wang L, Jiang S, Fu L, Buggs J, Liu R. New mouse model of chronic kidney disease transitioned from ischemic acute kidney injury. Am J Physiol Renal Physiol 2019;317:F286-95. [PMID: 31116604 DOI: 10.1152/ajprenal.00021.2019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
6 Baligand C, Qin H, True-Yasaki A, Gordon JW, von Morze C, Santos JD, Wilson DM, Raffai R, Cowley PM, Baker AJ, Kurhanewicz J, Lovett DH, Wang ZJ. Hyperpolarized 13 C magnetic resonance evaluation of renal ischemia reperfusion injury in a murine model. NMR Biomed 2017;30. [PMID: 28708304 DOI: 10.1002/nbm.3765] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
7 Fu Y, Tang C, Cai J, Chen G, Zhang D, Dong Z. Rodent models of AKI-CKD transition. Am J Physiol Renal Physiol 2018;315:F1098-106. [PMID: 29949392 DOI: 10.1152/ajprenal.00199.2018] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 11.5] [Reference Citation Analysis]
8 Wang Z, Li Y, Wang Y, Zhao K, Chi Y, Wang B. Pyridoxamine alleviates high glucose induced fibrosis in renal tubular epithelial cell by inhibiting the activity of TGF-β1/Smad3 signaling pathway. Diabetic Nephropathy 2022;0. [DOI: 10.2478/dine-2022-0005] [Reference Citation Analysis]
9 Chiusa M, Hu W, Liao HJ, Su Y, Borza CM, de Caestecker MP, Skrypnyk NI, Fogo AB, Pedchenko V, Li X, Zhang MZ, Hudson BG, Basak T, Vanacore RM, Zent R, Pozzi A. The Extracellular Matrix Receptor Discoidin Domain Receptor 1 Regulates Collagen Transcription by Translocating to the Nucleus. J Am Soc Nephrol 2019;30:1605-24. [PMID: 31383731 DOI: 10.1681/ASN.2018111160] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
10 Alshanwani AR, Hagar H, Shaheen S, Alhusaini AM, Arafah MM, Faddah LM, Alharbi FM, Sharma AK, Badr AM. A promising antifibrotic drug, pyridoxamine attenuates thioacetamide-induced liver fibrosis by combating oxidative stress, advanced glycation end products, and balancing matrix metalloproteinases. Eur J Pharmacol 2022;:174910. [PMID: 35339478 DOI: 10.1016/j.ejphar.2022.174910] [Reference Citation Analysis]
11 Zhan Y, Zhu M, Liu S, Lu J, Ni Z, Cai H, Zhang W. MicroRNA‑93 inhibits the apoptosis and inflammatory response of tubular epithelial cells via the PTEN/AKT/mTOR pathway in acute kidney injury. Mol Med Rep 2021;24:666. [PMID: 34296286 DOI: 10.3892/mmr.2021.12305] [Reference Citation Analysis]
12 Tod P, Bukosza EN, Róka B, Kaucsár T, Fintha A, Krenács T, Szénási G, Hamar P. Post-Ischemic Renal Fibrosis Progression Is Halted by Delayed Contralateral Nephrectomy: The Involvement of Macrophage Activation. Int J Mol Sci 2020;21:E3825. [PMID: 32481551 DOI: 10.3390/ijms21113825] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Scarfe L, Menshikh A, Newton E, Zhu Y, Delgado R, Finney C, de Caestecker MP. Long-term outcomes in mouse models of ischemia-reperfusion-induced acute kidney injury. Am J Physiol Renal Physiol 2019;317:F1068-80. [PMID: 31411074 DOI: 10.1152/ajprenal.00305.2019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
14 Zeng F, Miyazawa T, Kloepfer LA, Harris RC. ErbB4 deletion accelerates renal fibrosis following renal injury. Am J Physiol Renal Physiol 2018;314:F773-87. [PMID: 28724608 DOI: 10.1152/ajprenal.00260.2017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
15 Ergin B, Akin S, Ince C. Kidney Microcirculation as a Target for Innovative Therapies in AKI. J Clin Med 2021;10:4041. [PMID: 34575154 DOI: 10.3390/jcm10184041] [Reference Citation Analysis]
16 Shiva N, Sharma N, Kulkarni YA, Mulay SR, Gaikwad AB. Renal ischemia/reperfusion injury: An insight on in vitro and in vivo models. Life Sci 2020;256:117860. [PMID: 32534037 DOI: 10.1016/j.lfs.2020.117860] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Li Y, Liu X, Liu S, Lu J, Chen J, Xiong G, Yang S, Li S. Untargeted Metabolomics Reveals the Protective Effect of a Traditional Chinese Herbal Decoction on Cisplatin-Induced Acute Kidney Injury. Evid Based Complement Alternat Med 2020;2020:8524132. [PMID: 33101449 DOI: 10.1155/2020/8524132] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Zhu Y, He H, Tang Y, Peng Y, Hu P, Sun W, Liu P, Jin M, Xu X. Reno-Protective Effect of Low Protein Diet Supplemented With α-Ketoacid Through Gut Microbiota and Fecal Metabolism in 5/6 Nephrectomized Mice. Front Nutr 2022;9:889131. [DOI: 10.3389/fnut.2022.889131] [Reference Citation Analysis]
19 Göcze I, Wiesner C, Schlitt HJ, Bergler T. Renal recovery. Best Pract Res Clin Anaesthesiol 2017;31:403-14. [PMID: 29248146 DOI: 10.1016/j.bpa.2017.08.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
20 Menshikh A, Scarfe L, Delgado R, Finney C, Zhu Y, Yang H, de Caestecker MP. Capillary rarefaction is more closely associated with CKD progression after cisplatin, rhabdomyolysis, and ischemia-reperfusion-induced AKI than renal fibrosis. Am J Physiol Renal Physiol 2019;317:F1383-97. [PMID: 31509009 DOI: 10.1152/ajprenal.00366.2019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]